Breakfast Brief
ESMO 2019: “In lung cancer, you have to start with the best treatment first”
Prof. Solange Peters, MD, PhD, CHUV Lausanne, about the OS update of the FLAURA trial and disappointing news for immunotherapy in mesothelioma with the PROMISE-meso trial.
